Details for Patent: 5,639,738
✉ Email this page to a colleague
Summary for Patent: 5,639,738
Title: | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
Abstract: | A method of treating a mammal for a condition of the skin or exposed tissue selected from the group consisting of basal cell carcinoma and actinic keratosis is provided. The method consists essentially of topically administering to the site of the condition, more than once per day over a period of days sufficient to treat the condition, a non-toxic effective dosage amount of a composition consisting essentially of (a) a non-steroidal anti-inflammatory drug (NSAID) in an amount sufficient to block prostaglandin synthesis, (b) hyaluronic acid or a pharmaceutically acceptable salt thereof in an amount effective to transport said NSAID into the skin or exposed tissue at the site of the condition. The concentration of the hyaluronic add or salt thereof is between 1-3% by weight of the composition. The molecular weight of the hyaluronic acid or salt thereof is between 150,000 and 750,000 Daltons. A pharmaceutical excipient suitable for topical application is included. The NSAID in the composition may be diclofenac sodium. |
Inventor(s): | Falk; Rudolf Edgar (Toronto, CA), Asculai; Samuel Simon (Toronto, CA) |
Assignee: | Hyal Pharmaceutical Corporation (Mississauga, CA) |
Application Number: | 07/838,675 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 5,639,738
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,639,738
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Canada | 2061566 | Feb 20, 1992 |
International Family Members for US Patent 5,639,738
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 175 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 448 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 475 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 476 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 618 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 9000206 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 9300491 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |